ArticleVaccines2022
Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy.
Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
70 citing papers in PubMed, 91 citations in OpenAlex.
- Using the Diffusion of Innovation Theory to Understand COVID-19 Booster Hesitancy in Adults.International journal of environmental research and public health · 2026Article
- Factors associated with COVID-19 booster dose uptake in the Jazan region, Saudi Arabia: insights for policy improvement during pandemics.Frontiers in public health · 2026Article
- Article
- Influencing factors and dynamic changes of COVID-19 vaccine hesitancy in China: From the perspective of machine learning analysis.Human vaccines & immunotherapeutics · 2025Article
- A cross-sectional study of the predictors of COVID-19 vaccine hesitancy in Pakistan.Human vaccines & immunotherapeutics · 2025Article
- Healthcare workers' willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo.Human vaccines & immunotherapeutics · 2024Article
- Factors associated with the COVID-19 booster vaccine intentions of young adults in the United States.Human vaccines & immunotherapeutics · 2024Article
- Willingness to Receive COVID-19 Booster Dose Using the Health Belief Model (HBM) Among University Students: Cross-Sectional Study.Journal of clinical medicine · 2024Article
- Using cluster analysis to explore COVID-19 vaccine booster hesitancy by levels of medical mistrust in fully vaccinated US adults.Annals of medicine · 2024Article
- Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study.Narra J · 2024Article
- Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.Vaccine: X · 2024Review
- I want to be safe: understanding the main drivers behind vaccination choice throughout the pandemic.BMC public health · 2024Article
- Article
- The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.PloS one · 2024Article
- Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.Vaccine: X · 2024Article
- Article
- COVID-19 vaccine literacy: A scoping review.Human vaccines & immunotherapeutics · 2023Article
- Bivalent second booster dose of the COVID-19 vaccine: Eligible populations' reasons for receiving in Italy.Human vaccines & immunotherapeutics · 2023Article
- Age and partisan self-identification predict uptake of additional COVID-19 booster doses: Evidence from a longitudinal study.Preventive medicine reports · 2023Article
- Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study.Heliyon · 2023Article
10 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional study, conducted in Naples (Italy) between 16 November and 6 December 2021, explored the willingness to receive the booster dose of the COVID-19 vaccine among a random sample selected from the list of those who had completed a primary vaccination series at the immunization center of a teaching hospital in Naples and the associated factors. Females had a significantly higher perceived risk of getting the SARS-CoV-2 infection, whereas those not-having a cohabitant were less worried. 85.7% were willing to receive the booster dose. Those older respondents who perceived a better health status after the primary vaccination series, who have friends/family members who were diagnosed with COVID-19, who had received information from official government organizations, and those who did not need information would be willing to get the booster dose. 24.7% was hesitant with a Vaccine Hesitancy Scale (VHS) score ≥ 25. Respondents who self-rated a lower health status after the primary vaccination series, who did not have friends/family members who were diagnosed with COVID-19, who had not received information from official government organizations, and who needed information were hesitant. Information and communication regarding the benefits and efficacy of the booster dose are needed in order to control the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.